Streetbeat News

Products Services

AMZN

AZUL

Amazon has partnered with Azul Linhas Aéreas Brasileiras to enhance its package delivery capacity in the North region of Brazil. The agreement will allow Amazon customers in the region to receive orders transported on Azul planes within two to three days. The move is part of Amazon's strategy to improve its logistics network and delivery performance in Brazil, where it serves 100% of the municipal districts through its operation and third-party partners.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2023 | 2:57 pm

BIIB

Biogen has reported favorable trends for high-dose groups on multiple exploratory measures of cognition and function in a Phase 1b study. The study is of a Tau targeting drug that shows reduction of aggregated Tau pathology and favorable trends on clinical outcomes.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2023 | 2:54 pm

BA

GD

GOOG

MSFT

TMUS

TSM

TXN

The article discusses the impact of artificial intelligence (AI) on the performance of major companies, particularly Alphabet Inc (GOOG), Microsoft Corp (MSFT), Texas Instruments Inc (TXN), and Taiwan Semiconductor Mfg. Co. Ltd. (TSM). It suggests that Microsoft's lead in AI has helped it attract more clients to its cloud, while Alphabet's lagging cloud growth is due to its weaker AI capabilities. Similarly, TSM's exposure to AI is seen as a positive factor, while TXN's lack of AI exposure is viewed negatively. The article also mentions positive earnings from Boeing Co (BA), General Dynamics Corp (GD), and T-Mobile Us Inc (TMUS).

Portfolio Pulse from The Arora Report

October 25, 2023 | 2:53 pm

BIIB

Biogen Inc. (NASDAQ:BIIB) reported promising Phase 1b clinical data for its investigational antisense oligonucleotide (ASO) therapy, BIIB080, targeting tau in mild Alzheimer's disease. The data showed favorable trends on multiple exploratory endpoints of cognition and daily living activities. The study is the first to show a reduction of aggregated tau pathology and favorable trends on clinical outcomes with a tau targeting drug. Recruitment is underway for the Phase 2 CELIA study to further investigate clinical efficacy and safety.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2023 | 2:51 pm

BA

Boeing's CFO has announced during an investor call that the company still plans to resume production of the 777X later this year.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2023 | 2:49 pm

BA

Boeing's CFO has stated in an investor call that the company expects the number of 737 deliveries in October to be similar to those in September.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2023 | 2:47 pm

CDNS

PFE

Cadence Design Systems' business unit, Cadence Molecular Sciences, has expanded Pfizer's license to its molecular design software. The software, which uses physics and AI-based modeling, aids in early-stage drug discovery and is used by major pharmaceutical and biotech companies. The expanded agreement aims to enable high-quality science at the frontier of medicine.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2023 | 2:46 pm

BA

During an investor call, Boeing's CEO confirmed that the development schedules for Max 7, Max 10, and 777x remain unchanged.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2023 | 2:40 pm

BA

Boeing's CEO has announced that they are keeping suppliers on a master schedule for the production ramp-up of the 737. This was revealed during an investor call.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2023 | 2:38 pm

BA

Boeing's CEO has reported increased stability in the company's factories and is working to bring the supply chain up to the same standard. This information was shared during an investor call.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2023 | 2:37 pm